bioRxiv Science⌕ Search

Biology subjects

Fatunla, O. E.

Publications and source records attributed to Fatunla, O. E..

2 recordsLinked to original sources

DNA methylation profiles in urothelial bladder cancer tissues and children with schistosomiasis from Eggua, Ogun State, Nigeria

AbstractSquamous cell carcinoma has been attributed to chronic schistosomiasis and is the predominant type of bladder cancer in schistosomiasis endemic areas. The aim of this study was to assess early promoter DNA methylation in selected genes implicated in schistosomiasis-associated bladder cancer (SABC). A total of 161 urine samples were collected from school aged children in Eggua Community of Ogun State and examined by microscopy for Schistosoma haematobium eggs. From this sample, a subset of 34(21.1%) urine samples positive for S. haematobium eggs and 22 formalin fixed paraffin-embedded bladder cancer tissues obtained from the University College Hospital Ibadan, were subjected to DNA isolation and bisulfite DNA conversion. Quantitative methylation specific PCR was used to determine the methylation status of APC, RAR{beta}2, RASSF1A and TIMP3 in the samples. Methylation in APC, RAR{beta}2, RASSF1A and TIMP3 was observed in 24(70.6%), 18(52.9%), 15(44.1%) and 8(23.5%) of the positive urine samples respectively and in 7(31.8%), 13(59.1%), 17(77.3%) and 8(36.4%) of bladder cancer tissues respectively. APC, RAR{beta}2 and RASSF1A were 5-fold, 2-fold and 27-fold downregulated respectively in positive urine samples and 9-fold, 3-fold and 15-fold downregulated respectively in the bladder cancer tissues. The odds of promoter methylation in RAR{beta}2 (OR: 1.133) were likely even with light infection. Gene promoter DNA methylation in tumour suppressor genes was observed in schistosomiasis cases. Hence, DNA methylation may occur during active Schistosoma haematobium in children. This result may serve as an early non-invasive biomarker to detect and hint at the risk of developing SABC later in life. Author summarySchistosoma haematobium can survive in the host for more than 20 years, during which time it causes damage to the bladder tissues and sometimes with no symptoms. Immune response to the parasite infection is inflammatory and leads to several morbidities like anaemia, undernutrition, dysuria, and female genital sores and may result in malignant transformation (schistosomiasis-associated bladder cancer) which presents in later years. Children are more susceptible to schistosomiasis because of having a naive immune system, making them targets for these morbidities, and including the possibility of developing bladder cancer in later years. DNA methylation which is often the first step in malignant transformation is known to be induced by inflammation during chronic schistosomiasis. Hence, assessing DNA methylation can serve as a biomarker for predicting the risk of developing bladder cancer later in life. In this study, we have established that DNA methylation occurs during childhood schistosomiasis and represents the time when events leading up to malignant transformation may begin. We suggest that once there is a schistosomiasis infection, DNA methylation will occur and unless the disease is treated on time, the individual is at risk of malignant transformation later in life.

pathology↗

Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains

High-grade gliomas are aggressive primary brain cancers with poor response to standard regimens, driven by immense heterogeneity. In isocitrate dehydrogenase (IDH) wild-type high-grade glioma (glioblastoma, GBM), increased intra-tumoral heterogeneity is associated with more aggressive disease. Recently, spatial technologies have emerged to dissect this complex heterogeneity within the tumor ecosystem by preserving cellular organization in situ. Here, we construct a high-resolution molecular landscape of GBM and IDH-mutant high-grade glioma patient samples to investigate the cellular subtypes and spatial communities that compose high-grade glioma using digital spatial profiling and spatial molecular imaging. This uncovered striking diversity of the tumor and immune microenvironment, that is embodied by the heterogeneity of the inferred copy-number alterations in the tumor. Reconstructing the tumor architecture revealed two distinct niches, one composed of tumor cell states that most closely resemble normal glial cells, associated with microglia; and the other niche populated by monocytes and mesenchymal tumor cells. We further reveal that communication between tumor and immune cells is underpinned by tumor-specific ligands, such as TGF{beta} signaling in astrocyte-like tumor cells. This primary study reveals high levels of intra-tumoral heterogeneity in high-grade gliomas, associated with a diverse immune landscape within spatially localized regions.

cancer biology↗